Financials Burcon NutraScience Corporation

Equities

BU

CA1208311029

Food Processing

Market Closed - Toronto S.E. 03:59:47 2024-04-26 pm EDT 5-day change 1st Jan Change
0.245 CAD +6.52% Intraday chart for Burcon NutraScience Corporation +22.50% +11.36%

Valuation

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Capitalization 1 22.85 16.26 89.06 506.9 129.4 29.36
Enterprise Value (EV) 1 21.33 19.01 80.76 492.9 122.4 33.07
P/E ratio -3.57 x -3.4 x -15.7 x -780 x -12.6 x -1.16 x
Yield - - - - - -
Capitalization / Revenue 466 x 405 x 2,860 x 1,960 x 754 x 80.7 x
EV / Revenue 435 x 473 x 2,594 x 1,906 x 714 x 90.9 x
EV / EBITDA -3.92 x -4.27 x -21.9 x -103 x -16.1 x -4.54 x
EV / FCF -7.26 x -7.85 x -37.1 x -187 x -33.9 x -9.3 x
FCF Yield -13.8% -12.7% -2.69% -0.54% -2.95% -10.8%
Price to Book 9.74 x -8.21 x 3.88 x 14 x 4.58 x 7.1 x
Nbr of stocks (in thousands) 43,942 43,942 96,800 108,307 108,709 108,729
Reference price 2 0.5200 0.3700 0.9200 4.680 1.190 0.2700
Announcement Date 6/18/18 7/2/19 6/29/20 6/29/21 6/27/22 6/28/23
1CAD in Million2CAD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Net sales 1 0.049 0.0402 0.0311 0.2586 0.1715 0.3639
EBITDA 1 -5.442 -4.452 -3.686 -4.779 -7.582 -7.286
EBIT 1 -5.59 -4.552 -3.723 -4.856 -7.738 -7.525
Operating Margin -11,403.94% -11,330.3% -11,958.4% -1,877.56% -4,512.57% -2,067.88%
Earnings before Tax (EBT) 1 -5.623 -4.777 -4.652 -0.6175 -10.29 -25.42
Net income 1 -5.623 -4.777 -4.633 -0.6175 -10.26 -25.36
Net margin -11,471.79% -11,890.83% -14,882.42% -238.74% -5,982.59% -6,969.87%
EPS 2 -0.1456 -0.1087 -0.0587 -0.006001 -0.0945 -0.2333
Free Cash Flow 1 -2.937 -2.423 -2.174 -2.641 -3.608 -3.558
FCF margin -5,992.33% -6,031.02% -6,982.52% -1,021.21% -2,104% -977.61%
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 6/18/18 7/2/19 6/29/20 6/29/21 6/27/22 6/28/23
1CAD in Million2CAD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: March 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3
Net sales 1 0.0317 0.0446 0.0772 0.0905 0.1122 0.1612
EBITDA 1 -1.293 -1.35 -2.412 -1.749 -1.62 -1.278
EBIT - - - - - -
Operating Margin - - - - - -
Earnings before Tax (EBT) - - - - - -
Net income -1.354 - - - - -
Net margin -4,275.21% - - - - -
EPS -0.0100 - - -0.0400 - -
Dividend per Share - - - - - -
Announcement Date 11/15/21 2/14/22 6/27/22 8/15/22 11/7/22 2/14/23
1CAD in Million
Estimates

Balance Sheet Analysis

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Net Debt 1 - 2.75 - - - 3.71
Net Cash position 1 1.52 - 8.3 13.9 6.93 -
Leverage (Debt/EBITDA) - -0.618 x - - - -0.5098 x
Free Cash Flow 1 -2.94 -2.42 -2.17 -2.64 -3.61 -3.56
ROE (net income / shareholders' equity) -174% -2,618% -44.2% -2.09% -31.8% -157%
ROA (Net income/ Total Assets) -57.1% -72% -13.8% -8.8% -14.4% -24%
Assets 1 9.844 6.635 33.58 7.018 71.14 105.8
Book Value Per Share 2 0.0500 -0.0500 0.2400 0.3300 0.2600 0.0400
Cash Flow per Share 2 0.0800 0.0100 0.1600 0.1300 0.0600 0.0100
Capex 1 0.02 0.02 0.1 0.89 0.05 0.36
Capex / Sales 40.97% 46.18% 325% 345.85% 30.04% 98.9%
Announcement Date 6/18/18 7/2/19 6/29/20 6/29/21 6/27/22 6/28/23
1CAD in Million2CAD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. BU Stock
  4. Financials Burcon NutraScience Corporation